Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.
Recombinant alpha-2b interferon was evaluated in two controlled trials, each lasting for 2 months or more, with different dose levels and schedules of administration. The first study was conducted during a period of transmission of type A (H1N1) and type B influenza. At 2.5 x 10(6) IU per day, no ef...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1988
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172096/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2831814/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.1.47 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|